Organogenesis
ORGO
NASDAQ
IPO2016
about ORGO
Organogenesis is a biotechnology company focused on developing advanced therapies for tissue repair and regeneration, including engineered skin substitutes and biologics to address unmet medical needs in wound care and burns.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $2.71 | $2.77 | $2.62 | $348.62M | 668.52K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.11 | n/a | 2.43 | 13.74% | 14.30% | 0% |